Matinas BioPharma Holdings financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

마티나스 바이오파머 홀딩스NYSEAMERICAN:MTNB · NYSE Amex · Healthcare · sector #17

$3.01+6.74%

2026-10-06 close

Matinas BioPharma Holdings's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$25M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy